Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.073 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |